Making the Call: Improving Heart Failure Outcomes with SGLT2 Inhibitors

Sponsored by AstraZenecaPeer-to-Peer and Patient Consulting Conversation on the Multidimensional Outcomes with SGLT2 Inhibitors

PAID ADVERTISEMENT

Watch as cardiologists grapple with conundrums and reach across specialties for an interprofessional heart failure collaboration. Along with an impactful patient message, we will bring together the full care team to improve patient outcomes.

This event is not part of the official Scientific Sessions Conference 2022 as planned by the AHA Committee on Scientific Sessions Programming

Click here to download